Author:
Zhang Chunyu,Li Minghao,Liu Lin,Deng Li,Yulei Xie,Zhong Yi,Liao Bin,Yu Lu,Feng Jian
Abstract
Abstract
Background
The Systemic Immune-Inflammation Index (SII), a novel marker of inflammation based on neutrophil, platelet, and lymphocyte counts, has demonstrated potential prognostic value in patients undergoing percutaneous coronary intervention (PCI). Our aim was to assess the correlation between the SII and major adverse cardiovascular events following percutaneous coronary intervention.
Methods
We searched PubMed, Web of Science, Embase, and The Cochrane Library from inception to November 20, 2023, for cohort studies investigating the association between SII and the occurrence of MACEs after PCI. Statistical analysis was performed using Revman 5.3, with risk ratios (RRs) and 95% confidence intervals (CIs) as relevant parameters.
Results
In our analysis, we incorporated a total of 8 studies involving 11,117 participants. Our findings revealed that a high SII is independently linked to a increased risk of MACEs in PCI patients (RR: 2.08,95%CI: 1.87–2.32, I2 = 42%, p < 0.00001). Additionally, we demonstrated the prognostic value of SII in all-cause mortality, heart failure, and non-fatal myocardial infarction.
Conclusions
Elevated SII may serve as a potential predictor for subsequent occurrence of MACEs in patients undergoing PCI.
Trial registration
Our protocol was registered in PROSPERO (registration number: CRD42024499676).
Funder
Sichuan Science and Technology Program
Luzhou Municipal People's Government - Southwest Medical University Science and Technology Strategic Cooperation
Hejiang People's Hospital - Southwest Medical University Science and Technology Strategic Cooperation Project
Gulin County People's Hospital - Affiliated Hospital of Southwest Medical University Science and Technology strategic Cooperation
China International Medical Foundation
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献